HQH - Tekla Healthcare Investors
NYSE
->
Financial Services
->
Asset Management
Boston,
United States
Type: Equity
HQH price evolution
HQH
| (in millions $) | 30 Oct 2023 | 1 May 2023 | 30 Oct 2022 | 1 May 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0 | $0 | ||
| Short term investments | ||||
| Net receivables | $6.85 | $0.1 | $2.9 | $6.18 |
| Inventory | ||||
| Total current assets | $6.9 | $0.2 | $2.9 | $41.26 |
| Long term investments | $902.01 | |||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $932.49 | $990.8 | $926.3 | $1029.8 |
| Current liabilities | ||||
| Accounts payable | $10.4 | $8.5 | $11.5 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1.15 | $11.7 | $9.7 | $12.86 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1.15 | $11.7 | $9.7 | $12.86 |
| Shareholders' equity | ||||
| Retained earnings | $5.97 | $69.4 | $24.8 | $142.88 |
| Other shareholder equity | ||||
| Total shareholder equity | $1016.94 | |||
| (in millions $) | 30 Oct 2023 | 30 Oct 2022 | 29 Sep 2021 | 29 Sep 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0 | $0 | ||
| Short term investments | ||||
| Net receivables | $6.85 | $2.9 | $4.05 | $4.32 |
| Inventory | ||||
| Total current assets | $6.9 | $2.9 | $12.4 | $6.84 |
| Long term investments | $1071.7 | $996.8 | ||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $932.49 | $926.3 | $1172.54 | $1055.82 |
| Current liabilities | ||||
| Accounts payable | $8.5 | $11.3 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1.15 | $9.7 | $15.63 | $1.09 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1.15 | $9.7 | $15.63 | $1.12 |
| Shareholders' equity | ||||
| Retained earnings | $5.97 | $24.8 | $303.1 | $239.52 |
| Other shareholder equity | ||||
| Total shareholder equity | $1156.9 | $1054.7 | ||
| (in millions $) | 30 Oct 2023 | 1 May 2023 | 30 Oct 2022 | 1 May 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4.66 | $5.63 | $4.32 | $3.96 |
| Cost of revenue | ||||
| Gross Profit | -$0.57 | $0.32 | -$0.91 | -$1.74 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $0.45 | $0.48 | $0.53 | $0.5 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$25.81 | $83.33 | -$77.75 | -$120.43 |
| Net income | ||||
| Net income | -$26.83 | $83.16 | -$79.18 | -$115.05 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2023 | 30 Oct 2022 | 29 Sep 2021 | 29 Sep 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10.29 | $8.27 | $6.48 | $8.93 |
| Cost of revenue | ||||
| Gross Profit | -$0.25 | -$2.64 | $6.48 | $8.93 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $12.71 | $10.9 | ||
| Total operating expenses | $0.93 | $1.03 | $12.71 | $10.9 |
| Operating income | -$6.23 | -$1.97 | ||
| Income from continuing operations | ||||
| EBIT | -$6.23 | -$1.97 | ||
| Income tax expense | ||||
| Interest expense | $57.52 | -$198.18 | ||
| Net income | ||||
| Net income | $56.33 | -$194.23 | $155.18 | $241.2 |
| Income (for common shares) | $155.18 | $241.2 | ||
| (in millions $) | 30 Mar 2022 | 30 Dec 2021 | 29 Sep 2021 | 29 Jun 2021 |
|---|---|---|---|---|
| Net income | -$57.52 | -$57.52 | $33.3 | $33.3 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 29 Sep 2021 | 29 Sep 2020 | 29 Sep 2019 | 29 Sep 2018 |
|---|---|---|---|---|
| Net income | $155.18 | $241.2 | -$145.29 | $69.2 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
News
Fundamentals
| Market cap | $782.67M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 49.44M |
| Revenue | $18.57M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$137.90M |
| Revenue Q/Q | 135.81% |
| Revenue Y/Y | 172.11% |
| P/E ratio | -5.68 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 42.14 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.00 |
| EPS | -$2.79 |
|---|---|
| ROA | -14.22% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 6.01 |
| Quick ratio | N/A |